Drug Shortage Report for TEVA-MEDROXYPROGESTERONE
| Report ID | 99938 |
| Drug Identification Number | 02221306 |
| Brand name | TEVA-MEDROXYPROGESTERONE |
| Common or Proper name | MEDROXYPROGESTERONE 10MG TABS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | MEDROXYPROGESTERONE ACETATE |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | G03DA |
| ATC description | PROGESTOGENS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-11-28 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2021-10-14 |
| Company comments | Item is on suspended supply |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v21 | 2021-10-14 | French | Compare |
| v20 | 2021-10-14 | English | Compare |
| v19 | 2021-08-24 | French | Compare |
| v18 | 2021-08-24 | English | Compare |
| v17 | 2021-03-25 | French | Compare |
| v16 | 2021-03-25 | English | Compare |
| v15 | 2020-09-03 | French | Compare |
| v14 | 2020-09-03 | English | Compare |
| v13 | 2020-08-20 | French | Compare |
| v12 | 2020-08-20 | English | Compare |
| v11 | 2020-07-16 | French | Compare |
| v10 | 2020-07-16 | English | Compare |
| v9 | 2020-06-04 | French | Compare |
| v8 | 2020-06-04 | English | Compare |
| v7 | 2020-02-07 | French | Compare |
| v6 | 2020-02-07 | English | Compare |
| v5 | 2020-01-09 | French | Compare |
| v4 | 2020-01-09 | English | Compare |
| v3 | 2019-11-29 | English | Compare |
| v2 | 2019-11-28 | French | Compare |